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Background:  Increasing numbers of patients are undergoing evaluation for transcatheter aortic valve replacement, which often involves 
assessment of coronary artery disease ischemic burden. The safety and diagnostic accuracy of commonly used vasodilator stress agents 
in patients with severe aortic stenosis undergoing SPECTMPI has not been established
methods:  All patients with severe aortic stenosis (aortic valve area ≤ 1cm2 and peak velocity > 3.5 m/s) who underwent a vasodilator 
stress SPECT MPI study from 2007 to 2014 were identified from an electronic database. Subjects were matched based on age, gender, 
BMI, and stressor to controls without aortic stenosis. The hemodynamic response to vasodilator stress was assessed as well as correlation 
to invasive angiography when available
results:  A total of 42 patients were identified with 33 patients undergoing regadenoson stress and 9 dipyridamole. Between regadenoson 
cases and controls there was no significant difference in the mean change in heart rate (18.9 ± 14.2 and 13.0 ± 10.7, p=0.065) and the 
mean change in diastolic blood pressure (-2.7 ± 9.2 and -4.8± 14.7, p=0.50). The change in systolic blood pressure was statistically 
significantly different (-9.6 ± 18.8 and -0.5 ± 13.4, p=0.026). With dipyridamole cases and controls the difference in systolic blood pressure 
change was not quite statistically significant (-12.0 ± 18.3 and 2.9 ± 17.4, p=0.09). There was no statistically significant differences in heart 
rate response (5.3±8.7 and 16.8 +/- 21.4, p=0.16) and diastolic blood pressure change (-1.9 ± 10.8 and 3.8 ± 8.6, p=0.23). Overall, 26.2% 
of vasodilator stress patients compared to 2.1% of controls had a systolic blood pressure decrease of >20 mmHg (p=0.003). In 27 subjects 
who had an angiogram, sensitivity, specificity and diagnostic accuracy of vasodilator stress MPI was 80.0%, 83.3%, and 81.4% respectively
conclusion:  Patients with severe aortic stenosis are more likely to have a hemodynamically significant drop in systolic blood pressure with 
vasodilator stress agents. Overall vasodilators have good sensitivity, specificity and diagnostic accuracy in severe aortic stenosis patients
